Annual Meeting- 2017
2017 Annual Meeting
September 25-27, 2017
San Diego Convention Center
Cancer is a leading cause of death worldwide. According to the World Health Organization (WHO), cancer deaths worldwide are projected to continue to rise to more than 11 million in 2030. The American Cancer Society estimates that in 2017, 1.685 million new cases of cancer will be diagnosed. Nearly two-thirds of these patients will receive radiation therapy during their illness – most with the intent to cure the cancer. Advances in the applications, technologies and methodologies of radiation oncology continue to evolve rapidly and the delivery of radiation therapy has become more complex, making it imperative that the radiation oncology professional remain current in the state-of-the-art techniques. ASTRO is committed to providing educational programming that creates a forum for global collaboration on issues in radiation oncology to improve professional practice by increasing their level of knowledge, as required to improve competency and performance in the field of oncology.
This continuing medical education activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation oncology nurses, radiation oncology administrators, diagnostic radiologists and all other health professionals involved in the field of radiation oncology.
At the conclusion of this activity, the learner will be able to:
- Examine the advances in radiation oncology technology that help improve patient outcomes and quality of life.
- Employ quality and safety measures in the delivery of radiation therapy.
- Demonstrate the value of radiation oncology to patients, referring physicians and the public.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 33.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a maximum of 33.92 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
This activity has been approved for 26 MDCB credits by the Medical Dosimetrist Certification Board.
This activity is no approved for nursing CEUs.
The ASTRO educational program is not approved for Category A CE credits accepted by ARRT. However, the educational program of the ASRT Radiation Therapy Conference, held in conjunction with the ASTRO Annual Meeting, is approved for Category A credit accepted by ARRT. Learn more.
- 33.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 33.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 26.00 MDCBThis activity has been approved for a maximum of 26.00 MDCB credits by the Medical Dosimetrist Certification Board.
- 33.92 CAMPEPThis activity has been approved for 33.92 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
- 33.50 Certificate of AttendanceThis activity was designated for 33.50 AMA PRA Category 1 Credit™.